← 返回

浸润性乳腺癌免疫谱分析的双重多重免疫染色:新兴的基于免疫的新型生物标志物

英文原题:Double-Multiplex Immunostainings for Immune Profiling of Invasive Breast Carcinoma: Emerging Novel Immune-Based Biomarkers.

查看英文原题

Double-Multiplex Immunostainings for Immune Profiling of Invasive Breast Carcinoma: Emerging Novel Immune-Based Biomarkers.

PubMed 2025/03/21(内容时间) Int J Mol Sci Q1 · IF 5.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

肿瘤微环境在浸润性乳腺癌预后和治疗中的作用备受重视。随着免疫治疗的出现,原发肿瘤的免疫表型特征分析正日益受到关注,因为它可以改善患者分层。在此,我们讨论采用双重和多重免疫染色进行空间分析的优势,这使得能够在同一组织切片上同时检测一种以上的蛋白质,从而有助于我们对肿瘤内浸润性免疫细胞提供功能性见解。我们重点关注那些证明不同TIL(肿瘤浸润淋巴细胞)亚群(包括不同的 CD8(+) T 细胞亚群以及 CD4(+) T 细胞和肿瘤相关巨噬细胞)在浸润性乳腺癌中具有预后和预测影响的研究。免疫细胞拓扑结构的临床价值也受到认可。我们进一步提及数字病理学和人工智能在常规实践中的整合如何能够提高肿瘤微环境内多重免疫染色评估的准确性,最大化我们对宿主免疫反应的认识,进而改善决策,推动更精准的免疫相关治疗。

展开英文摘要原文

The role of tumor microenvironment in invasive breast cancer prognosis and treatment is highly appreciated. With the advent of immunotherapy, immunophenotypic characterization in primary tumors is gaining attention as it can improve patient stratification.

Here, we discuss the benefits of spatial analysis employing double and multiplex immunostaining, allowing the simultaneous detection of more than one protein on the same tissue section, which in turn helps us provide functional insight into infiltrating immune cells within tumors.

We focus on studies demonstrating the prognostic and predictive impact of distinct tumor-infiltrating lymphocyte subpopulations including different CD8(+) T subsets as well as CD4(+) T cells and tumor-associated macrophages in invasive breast carcinoma. The clinical value of immune cell topography is also appreciated.

We further refer to how the integration of digital pathology and artificial intelligence in routine practice could enhance the accuracy of multiplex immunostainings evaluation within the tumor microenvironment, maximizing our perception of host immune response, improving in turn decision-making towards more precise immune-associated therapies.

论文信息

作者
Theodorou SDP、Ntostoglou K、Nikas IP、Goutas D、Georgoulias V、Kittas C、Pateras IS
第一作者单位
Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.Greece
通讯作者单位
2nd Department of Pathology, "Attikon" University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.Greece
文献类型
综述
期刊
International journal of molecular sciences2025 Mar 21
原文标识
PubMed 40243442 · DOI 10.3390/ijms26072838